Regulatory Conflicts Exposed

The conversation delves into the troubling relationship between regulatory agencies and the pharmaceutical industry, highlighting how nearly half of the FDA's budget is funded by user fees from the very industry it regulates. This creates a significant conflict of interest, compounded by the revolving door of high-level officials transitioning to roles within the pharmaceutical sector. The implications of these dynamics raise serious questions about the integrity of oversight in public health.